GB1535317A - Anti-cancer vaccines - Google Patents

Anti-cancer vaccines

Info

Publication number
GB1535317A
GB1535317A GB719575A GB719575A GB1535317A GB 1535317 A GB1535317 A GB 1535317A GB 719575 A GB719575 A GB 719575A GB 719575 A GB719575 A GB 719575A GB 1535317 A GB1535317 A GB 1535317A
Authority
GB
United Kingdom
Prior art keywords
media
virus
extract
feb
hcl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB719575A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HUNG CHIU HO
MUN HON NG W
WAI SING NG
Original Assignee
HUNG CHIU HO
MUN HON NG W
WAI SING NG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HUNG CHIU HO, MUN HON NG W, WAI SING NG filed Critical HUNG CHIU HO
Priority to GB719575A priority Critical patent/GB1535317A/en
Publication of GB1535317A publication Critical patent/GB1535317A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/80—Vaccine for a specifically defined cancer
    • A61K2039/804—Blood cells [leukemia, lymphoma]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

1535317 Anti cancer vaccines MUN HON NG WILSON WAI SING NG and HUNG CHIU HO 20 Feb 1976 [20 Feb 1975] 7195/75 Heading A5B Preparation of an extract from virus carrying lymphoblastoid cells, for use as a vaccine against tumors, comprises sequentially exposing the cells to media of varying ionic concentrations while maintaining the media at isotonicity to minimise cell lysis and thereafter separating an extract containing antigens which elicit tumor specific immune response and is virus and virus nuclei acid free. An extract, for use as a vaccine against nasopharyngeal carcinoma and Burkitt's lymphoma, can be prepared from Epstein Barr virus carrying lymphoblastoid cells utilising the media RPMI-1640, PBS, tris-HCl/ glycerol and ImM EDTA-HCl (as defined) sequentially.
GB719575A 1976-02-20 1976-02-20 Anti-cancer vaccines Expired GB1535317A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB719575A GB1535317A (en) 1976-02-20 1976-02-20 Anti-cancer vaccines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB719575A GB1535317A (en) 1976-02-20 1976-02-20 Anti-cancer vaccines

Publications (1)

Publication Number Publication Date
GB1535317A true GB1535317A (en) 1978-12-13

Family

ID=9828423

Family Applications (1)

Application Number Title Priority Date Filing Date
GB719575A Expired GB1535317A (en) 1976-02-20 1976-02-20 Anti-cancer vaccines

Country Status (1)

Country Link
GB (1) GB1535317A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0016735A2 (en) * 1979-05-18 1980-10-01 DEPA S.p.A. A process for obtaining a product for the diagnosis of carcinoma
WO2022062687A1 (en) * 2020-09-24 2022-03-31 刘慧宁 Combined tumor antigen, multivalent dendritic cell vaccine and use thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0016735A2 (en) * 1979-05-18 1980-10-01 DEPA S.p.A. A process for obtaining a product for the diagnosis of carcinoma
EP0016735A3 (en) * 1979-05-18 1981-04-15 Depa S.P.A. A process for obtaining a product for the diagnosis of carcinoma and kit for performing tests
WO2022062687A1 (en) * 2020-09-24 2022-03-31 刘慧宁 Combined tumor antigen, multivalent dendritic cell vaccine and use thereof

Similar Documents

Publication Publication Date Title
HU9500571D0 (en) Retro-, inverso-, and retro-inverso synthetic peptide analogues
CA2033640A1 (en) Vaccines against cancer and infectious diseases
GB1531762A (en) Cancer antigen cancer therapy and cancer diagnosis
EA199800272A1 (en) FACTOR, STIMULATING DENDRIT CELLS
IL74545A0 (en) Synthetic hepatitis b virus vaccine including both t cell and b cell determinants
KR970009347B1 (en) Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3
LU79477A1 (en) METHODS FOR PREPARING THE ANTIGEN OF THE HEPATITIS B CORE AND VACCINES CONTAINING IT
JPS5344613A (en) Tumor vaccine containing lectin/tumor cell-complex
NZ189756A (en) Muramyl peptides antigens covalently bonded to muramyl-peptides medicaments and vaccines
GB1535317A (en) Anti-cancer vaccines
GB1292803A (en) Improvements relating to the production of antigens
JPS55153723A (en) Manufacture of influenza virus vaccine in liquid cell culture
ZA761346B (en) Vaccine for active immunization containing hepatitis b surface antigen and associated antigen
AU1807776A (en) Detecting hepatitis antigen and antibodies and vaccine for hepatitis
GB1488800A (en) Influenza vaccines
Geizhals Attitudes toward death and dying: A study of occupational therapists and nurses.
DK467181A (en) VIRUS MUTANT OF SHV, VACCINE CONTAINING THIS MUTANT AND PROCEDURE FOR PREPARING THE VACCINE
Coggin Jr et al. Phase specific surface autoantigens on membranes of fetus and tumors
ATE18007T1 (en) HEPATITIS VACCINE.
Kojima et al. Interferon. Production by Bordetella pertussis Components in Rabbits and in Rabbit Cell Cultures
YU39039B (en) Process for the preparation of vinyl cloride homopolymerisates and heteropolymerisates
PH16230A (en) Specific antigen vaccine for tge in swine
FR2331354A2 (en) ACTIVE IMMUNIZATION AGAINST VIRAL HEPATITIS VACCINE AND PREPARATION METHOD
Khosravi Isolation and identification of melanoma antigens from human melanoma tumor cell membranes
Leibold et al. Brief Communication: Induction of Epstein-Barr Virus-Associated Nuclear Antigen During In Vitro Transformation of Human Lymphoid Cells 2

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee